Département d'Urologie et de Transplantation Rénale, Centre Hospitalier Universitaire, 2 rue de la Milétrie, F-86000 Poitiers, France.
Département d'Urologie Centre Hospitalier Universitaire, Aix-Marseille University, Assistance Publique Hôpitaux de Marseille, Marseille, France.
J Urol. 2024 Sep;212(3):461-469. doi: 10.1097/JU.0000000000004047. Epub 2024 May 16.
Current guidelines recommend screening and treatment of asymptomatic bacteriuria prior to all urological surgeries breaching the mucosa. But little evidence supports this recommendation. At the least, risk stratification for postoperative UTI to support this strategy is lacking. The aim of this study was to define the associated factors for postoperative febrile infectious complications (UTI or surgical site infection) in urological surgery.
We conducted a retrospective, multicentric study including all consecutive patients undergoing any urological surgery with preoperative urine culture. The primary outcome was the occurrence of a UTI or surgical site infection occurring within 30 days after surgery.
From 2016 to 2023, in 10 centers, 2389 patients were included with 838 (35%) positive urine cultures (mono-/bi-/polymicrobial). Postoperative infections occurred in 106 cases (4.4%), of which 44 had negative urine cultures (41%), 42 had positive mono-/bimicrobial urine cultures (40%), and 20 had polymicrobial urine cultures (19%). In multivariable analysis, UTI during the previous 12 months of surgery (odds ratio [OR] 3.43; 95% CI 2.07-5.66; < .001), monomicrobial/bimicrobial preoperative urine culture (OR 3.68; 95% CI 1.57-8.42; = .002), polymicrobial preoperative urine culture (OR 2.85; 95% CI 1.52-5.14; < .001), and operative time (OR 1.09; 95% CI 1.04-1.15; < .001) were independent associated factors for postoperative febrile infections.
Positive urine culture, including preoperative polymicrobial urine culture, prior to urological surgery was associated with postoperative infection. Additionally, patients experiencing infectious complications also had a higher incidence of other complications. The effectiveness of systematic preventive antibiotic therapy for a positive urine culture has not been conclusively established.
目前的指南建议在所有穿透黏膜的泌尿科手术前筛查和治疗无症状菌尿。但几乎没有证据支持这一建议。至少,缺乏支持这一策略的术后尿路感染风险分层。本研究旨在确定泌尿科手术中术后发热性感染并发症(尿路感染或手术部位感染)的相关因素。
我们进行了一项回顾性、多中心研究,纳入了所有接受术前尿培养的连续患者。主要结局是术后 30 天内发生尿路感染或手术部位感染。
2016 年至 2023 年,在 10 个中心共纳入 2389 例患者,其中 838 例(35%)尿培养阳性(单/双/多微生物)。术后感染 106 例(4.4%),其中 44 例尿培养阴性(41%),42 例单/双微生物尿培养阳性(40%),20 例多微生物尿培养阳性(19%)。多变量分析显示,手术前 12 个月内发生尿路感染(优势比 [OR] 3.43;95%CI 2.07-5.66; <.001)、术前单/双微生物尿培养(OR 3.68;95%CI 1.57-8.42; =.002)、术前多微生物尿培养(OR 2.85;95%CI 1.52-5.14; <.001)和手术时间(OR 1.09;95%CI 1.04-1.15; <.001)是术后发热感染的独立相关因素。
术前尿培养阳性,包括术前多微生物尿培养阳性,与术后感染相关。此外,发生感染并发症的患者其他并发症的发生率也更高。对于阳性尿培养,系统预防性使用抗生素治疗的效果尚未得到明确证实。